Key statistics
On Friday, INmune Bio Inc (INMB:NAQ) closed at 4.87, 9.44% above its 52-week low of 4.45, set on Nov 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.76 |
---|---|
High | 4.98 |
Low | 4.70 |
Bid | 4.81 |
Offer | 7.45 |
Previous close | 4.76 |
Average volume | 214.57k |
---|---|
Shares outstanding | 22.17m |
Free float | 15.80m |
P/E (TTM) | -- |
Market cap | 105.54m USD |
EPS (TTM) | -2.18 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
- INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer's Disease
- INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB
- INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination
- INmune Bio Inc. to Report Third Quarter 2024 Financial Results and Provide Corporate Update on October 31, 2024
- INmune Bio Inc. to Participate in the Maxim Healthcare Virtual Summit
- INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease
- INKmune™ Demonstrates Excellent Safety and Increased NK-Cell Activity in First Dosing Cohort
- INmune Bio Announces Results of Additional Blinded Interim Analysis of Phase 2 Alzheimer's Disease Trial Demonstrating Correlation between EMACC and CDR-SB Endpoints
- INmune Bio Announces $13.0 Million Registered Direct Offering
- INmune Bio Inc. to Present at the Baird 2024 Global Healthcare Conference
More ▼